POLYMED — Poly Medicure Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Poly Medicure, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,872	7,865	9,231	11,152	13,758
Cost of Revenue
Gross Profit	4,016	4,500	4,898	6,059	8,932
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	5,637	6,196	7,639	9,067	10,815
Operating Profit	1,235	1,669	1,591	2,085	2,943
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,257	1,801	1,952	2,375	3,443
Provision for Income Taxes
Net Income After Taxes	959	1,359	1,465	1,793	2,583
Net Income Before Extraordinary Items
Net Income	959	1,359	1,465	1,793	2,583
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	959	1,359	1,465	1,793	2,583
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	10.9	15.2	15.2	18.7	26.9
Dividends per Share